Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000102909-25-000210·RHYTHM PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
Rhythm Pharmaceuticals Inc
Common Stock · CUSIP: 76243J105
Event date: 2025-09-30
- Filing-level shares
- 4,996,427
- Percent of class
- 7.52%
- The Vanguard Group
Shares: 4,996,427 · Class: 7.52%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000210
- Form type
- SCHEDULE 13G/A
- Filer
- RHYTHM PHARMACEUTICALS, INC.
- CIK
- CIK 1649904
- Filed
- Oct 30, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership